Fosfomycin Dosing
For uncomplicated cystitis in adult women, use fosfomycin 3 grams as a single oral dose; for complicated UTIs or systemic infections, fosfomycin should NOT be used as first-line therapy based on current guidelines, though IV fosfomycin 6 grams every 8 hours may be considered for complicated upper UTIs when other options are limited. 1, 2
Adult Dosing by Clinical Scenario
Uncomplicated Cystitis (Women)
- Standard dose: 3 grams oral (single dose) 1, 2
- Mix powder with water before ingesting; never take dry 2
- Can be taken with or without food 2
- First-line recommendation per 2024 EAU guidelines 1
- Achieves urinary concentrations >700 mcg/mL within 2-4 hours, maintaining >100 mcg/mL for 48 hours 3
Uncomplicated Pyelonephritis
Oral fosfomycin should be AVOIDED - the 2024 EAU guidelines explicitly state there are insufficient data regarding efficacy for pyelonephritis 1. Use fluoroquinolones or cephalosporins instead.
Complicated UTIs (Upper Tract)
- IV fosfomycin: 6 grams every 8 hours for 7 days (14 days if concurrent bacteremia) 4, 5
- This regimen showed noninferiority to piperacillin-tazobactam in the ZEUS trial 4
- Particularly effective for ESBL-producing organisms in non-bacteremic patients 5
- Oral fosfomycin for complicated lower UTI: 3 grams every 48-72 hours for 3 total doses (off-label) 4
- Reserve for MDR pathogens, treatment failures, or intolerance to first-line agents
Systemic/Bacteremic Infections
Exercise caution - The FOREST trial showed fosfomycin did NOT meet noninferiority for MDR bacteremia with urinary source and had more treatment-limiting adverse effects 5. However, post-hoc DOOR analysis suggested potential benefit when considering ecological impact and oral step-down therapy 6.
For systemic infections requiring efficacious serum concentrations: 6-12 grams per day divided into 3 doses (oral or IV) based on pharmacokinetic modeling 7.
Pediatric Dosing
Insufficient evidence - Current guidelines provide no clear recommendation for duration or specific dosing in pediatric patients 8. Numerous RCTs suggest shorter durations (3-5 days) may be effective for cystitis in children >2 months, but heterogeneity in trial design precludes firm recommendations 8.
Renal Impairment Adjustments
Severe Renal Dysfunction
- Half-life increases dramatically: from 5.7 hours (normal) to 40-50 hours in anuric/severe impairment 3, 9
- Urinary recovery decreases from 32% to 11% 3
- Dose modification required when CrCl <50 mL/min 9
- In anuric patients on hemodialysis, t½ extends to 40 hours 3
Critical caveat: The FDA label states no dosage adjustment is required in renal impairment 3, but this contradicts pharmacokinetic data showing significant accumulation 9. In severe renal impairment (CrCl <30 mL/min), consider alternative agents or extend dosing intervals significantly based on pharmacokinetic principles, despite lack of specific FDA guidance.
No Adjustment Needed
Key Clinical Pitfalls
Do not use oral fosfomycin for pyelonephritis - This is explicitly contraindicated by 2024 guidelines despite its availability 1
Single-dose limitation - The 3-gram single dose is ONLY appropriate for uncomplicated cystitis; complicated infections require multiple doses 4
Bacteremia concerns - Fosfomycin showed inferior outcomes in bacteremic UTIs in the FOREST trial 5, 6. Reserve for non-bacteremic patients or when alternatives exhausted.
Renal dosing ambiguity - Despite FDA stating no adjustment needed, pharmacokinetic data clearly shows accumulation in renal failure 3, 9. Monitor closely or avoid in severe renal impairment.
Food effects - While fosfomycin can be taken with food, high-fat meals delay peak urinary concentrations from 2-4 hours to 6-8 hours (though total excretion remains unchanged) 3
Drug interactions - Metoclopramide significantly lowers serum concentrations and urinary excretion; avoid coadministration 3